Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2350]
News [4895]
Articles [202]
Editorials [8]
Conferences [136]
elearning [14]
P53 could be key to therapies for salivary gland cancer
P53 could be key to therapies for salivary gland cancer
SABCS 2022: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
SABCS 2022: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and...
SABCS 2022: Treatment decision guided by CTC count may improve long-term outcomes for mBC
SABCS 2022: Treatment decision guided by CTC count may improve long-term outcomes for mBC
SABCS 2022: Neoadjuvant trastuzumab deruxtecan shows clinical activity in patients with HER2-low breast cancer
SABCS 2022: Neoadjuvant trastuzumab deruxtecan shows clinical activity in patients with HER2-low breast cancer
SABCS 2022: T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer
SABCS 2022: T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer
IAEA launches worldwide rays of hope partnership with 11 global cancer societies in cancer care
IAEA launches worldwide rays of hope partnership with 11 global cancer societies in cancer care
SABCS 2022: A genomic assay may predict long-term prognosis in premenopausal patients with hormone receptor-positive early-stage breast cancer
SABCS 2022: A genomic assay may predict long-term prognosis in premenopausal patients with hormone receptor...
SABCS 2022: HER2-low and HER2-zero triple-negative breast cancer show distinct biological differences
SABCS 2022: HER2-low and HER2-zero triple-negative breast cancer show distinct biological differences
SABCS 2022: SET2, 3 gene expression index shows prognostic value in early male breast cancer
SABCS 2022: SET2, 3 gene expression index shows prognostic value in early male breast cancer
SABCS 2022: Study identifies biomarker and driver for brain metastases in inflammatory breast cancer
SABCS 2022: Study identifies biomarker and driver for brain metastases in inflammatory breast cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation